| Literature DB >> 31035861 |
Megan M Haney1, Joseph Sinnott2, Kate L Osman2, Ian Deninger2, Ellyn Andel2, Victoria Caywood2, Alexis Mok2, Brayton Ballenger2, Kevin Cummings3, Lori Thombs4, Teresa E Lever2,3.
Abstract
The intricate sensorimotor neural circuits that control swallowing are heavily reliant on serotonin (5-hydroxytryptamine [5-HT]); however, the impact of 5-HT deficiency on swallow function remains largely unexplored. We investigated this using mice deficient in tryptophan-hydroxylase-2 (TPH2), the enzyme catalyzing the rate-limiting step in 5-HT synthesis. Videofluoroscopy was utilized to characterize the swallowing function of TPH2 knockout (TPH2-/-) mice as compared with littermate controls (TPH2+/+). Results showed that 5-HT deficiency altered all 3 stages of swallowing. As compared with controls, TPH2-/- mice had significantly slower lick and swallow rates and faster esophageal transit times. Future studies with this model are necessary to determine if 5-HT replacement may rescue abnormal swallowing function. If so, supplemental 5-HT therapy may have vast applications for a large population of patients with a variety of neurologic disorders resulting in life-diminishing dysphagia, particularly amyotrophic lateral sclerosis and Parkinson's disease, for which 5-HT deficiency is implicated in the disease pathogenesis.Entities:
Keywords: 5-hydroxytryptamine (5-HT); amyotrophic lateral sclerosis (ALS); mouse model; serotonin deficiency; tryptophan hydroxylase (TPH); videofluoroscopy
Mesh:
Substances:
Year: 2019 PMID: 31035861 PMCID: PMC8341204 DOI: 10.1177/0194599819846109
Source DB: PubMed Journal: Otolaryngol Head Neck Surg ISSN: 0194-5998 Impact factor: 3.497